Cognitive Behavioral Therapy for Hyperacusis
1 other identifier
interventional
62
1 country
1
Brief Summary
The main purpose of this study is to investigate whether cognitive behaviour therapy (CBT) can be useful for people suffering from Hyperacusis. Also, the investigators are interested in investigating this group of patients on psychiatric and somatic comorbidity, personality traits, and startle response to sounds. The investigators will also study the audiological measures commonly used in Sweden to measure hyperacusis, and investigate their validity. The investigators hypothesize that CBT might be helpful for patients suffering from Hyperacusis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 23, 2011
CompletedFirst Posted
Study publicly available on registry
March 24, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 28, 2014
May 1, 2014
6.5 years
March 23, 2011
May 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quality of Life Inventory (QOLI)
Inventory measuring how patients' percieve the importance of and their satisfaction with many variables that concludes life quality, for instance economy, physical health and family life.
Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
Khalfa Hyperacusis Questionnaire
A questionnaire to quantify and evaluate various hyperacusis symptoms, screening several aspects of auditory symptomatology.
Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
Loudness discomfort threshold
Audiological measure where the patient is exposed to sounds, gradually of higher volume. The patient is instructed to indicate when the sound level is uncomfortably loud, and that terminates the exposure. The test is performed by an audiologist using a calibrated audiometer.
Time Frame: (FDAAA) Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
Secondary Outcomes (4)
The Mini-International Neuropsychiatric Interview (M.I.N.I)
At evaluation for participance (day one)
Swedish universities Scales of Personality (SSP)
At evaluation for participance (day one)
Tampa scale of Kinesiophobia - for Hyperacusis
Evaluation for participance (day one), before treatment for waiting list patients (up to 6 months), direct after treatment, 12 mts after treatment
Startle-response
Evaluation for participance (day one), before treatment for waiting list patients (up to
Study Arms (2)
Cognitive behavioural therapy (CBT)
EXPERIMENTALPatients receiving 6 sessions of CBT conducted by a licensed psychologist. Sessions include psychoeducation, exposure treatment, behavioral activation and applied relaxation.
Waiting list
NO INTERVENTIONPatient waits for CBT treatment for 6 months.
Interventions
6 sessions by licensed psychologist, including psychoeducation, exposure therapy, applied relaxation and behavioral activation.
Eligibility Criteria
You may qualify if:
- Patient understands and can speak Swedish well
- Hyperacusis is the primary audiological problem
- Loudness discomfort thresholds below 90 dB
- Hearing levels better than 40dB on the best ear
- Resident of Uppsala, Stockholm or Vastmanland
- Possibility to travel to Uppsala or Vasteras for examination and treatment
You may not qualify if:
- Scoring "moderate" or "high" on suicidality, according to M.I.N.I
- Moderate to severe depression
- Psychotic disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Linkoeping Universitylead
- Uppsala Universitycollaborator
- Uppsala University Hospitalcollaborator
Study Sites (1)
Unknown Facility
Uppsala, 75185, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lisa Ekselius, Professor
Uppsala University
- STUDY CHAIR
Gerhard Andersson, Professor
Linkoeping University
- STUDY CHAIR
Hans C Larsen, Reader
Uppsala University Hospital
- PRINCIPAL INVESTIGATOR
Linda Jüris, PhD Student
Uppsala University/ Uppsala University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 23, 2011
First Posted
March 24, 2011
Study Start
June 1, 2004
Primary Completion
December 1, 2010
Study Completion
December 1, 2012
Last Updated
May 28, 2014
Record last verified: 2014-05